Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 53OTHER_GOV 5NIH 3FED 2INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 4Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Small Cell Lung Carcinoma 2Sprains and Strains 1Sepsis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lung Neoplasms 1Febrile Neutropenia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 49Capecitabine 42Radiotherapy 33Oxaliplatin 33Gemcitabine 33apatinib 32Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 20Nivolumab 19pembrolizumab 18fludarabine 18Metformin 16Exercise 16Radiation 15camrelizumab 14S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER_GOV × Simvastatin × Clear all
NCT01156545 2022-04-06

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

National Cancer Center, Korea

Phase 2 Completed
68 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01441349 2022-04-06

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

National Cancer Center, Korea

Phase 2 Unknown
192 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05133310 2022-01-04

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Hospital General de Mexico

Phase 4 Unknown
108 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Sprains and Strains, Sepsis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT00452244 2017-08-25

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

National Cancer Center, Korea

Phase 2 Completed
110 enrolled
Thoracic

Lung Neoplasms

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

National Cancer Center, Korea

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡